🇺🇸 ponsegromab in United States
50 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 20 April 2025 – 20 April 2026
- Total reports: 50
Most-reported reactions
- Acute Kidney Injury — 5 reports (10%)
- C-Reactive Protein Increased — 5 reports (10%)
- Cardiac Failure — 5 reports (10%)
- Confusional State — 5 reports (10%)
- Congestive Hepatopathy — 5 reports (10%)
- Disease Progression — 5 reports (10%)
- Fall — 5 reports (10%)
- Hydrocele — 5 reports (10%)
- Hypokalaemia — 5 reports (10%)
- Hypovolaemia — 5 reports (10%)
Other Other approved in United States
Frequently asked questions
Is ponsegromab approved in United States?
ponsegromab does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for ponsegromab in United States?
Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.